• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Capacity for brain amyloid PET in Germany: Results from the 1st survey on nuclear brain imaging in Germany.

作者信息

Buchert R, Drzezga A, Schreckenberger M, Meyer P T

机构信息

Department of Diagnostic and Interventional Radiology and Nuclear Medicine, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.

Institute of Neuroscience and Medicine (INM-2), Forschungszentrum Jülich, Jülich, Germany.

出版信息

Eur J Nucl Med Mol Imaging. 2025 Mar 27. doi: 10.1007/s00259-025-07237-8.

DOI:10.1007/s00259-025-07237-8
PMID:40140072
Abstract
摘要

相似文献

1
Capacity for brain amyloid PET in Germany: Results from the 1st survey on nuclear brain imaging in Germany.德国脑淀粉样蛋白PET的能力：德国首次核脑成像调查结果
Eur J Nucl Med Mol Imaging. 2025 Mar 27. doi: 10.1007/s00259-025-07237-8.
2
123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma.用于诊断神经母细胞瘤的123I-间碘苄胍闪烁扫描术和18F-氟代脱氧葡萄糖正电子发射断层显像
Cochrane Database Syst Rev. 2015 Sep 29;2015(9):CD009263. doi: 10.1002/14651858.CD009263.pub2.
3
Radiation protection and personal dosimetry in a core facility for multimodal small animal imaging.多模态小动物成像核心设施中的辐射防护与个人剂量测定
Rofo. 2025 Aug;197(8):913-925. doi: 10.1055/a-2462-2419. Epub 2024 Dec 4.
4
Comparison of tau spread in people with Down syndrome versus autosomal-dominant Alzheimer's disease: a cross-sectional study.唐氏综合征与常染色体显性阿尔茨海默病患者 Tau 蛋白扩散的比较：一项横断面研究。
Lancet Neurol. 2024 May;23(5):500-510. doi: 10.1016/S1474-4422(24)00084-X.
5
Predictive accuracy of amyloid imaging for progression from mild cognitive impairment to Alzheimer disease with different lengths of follow-up: a meta-analysis. [Corrected].不同随访时长下淀粉样蛋白成像对轻度认知障碍进展为阿尔茨海默病的预测准确性：一项荟萃分析。[已校正]
Medicine (Baltimore). 2014 Dec;93(27):e150. doi: 10.1097/MD.0000000000000150.
6
Self-reported frequency of handwashing among pet and non-pet owners in different situations: results of four surveys of the general adult population in Germany.德国普通成年人群四次调查结果：宠物主人与非宠物主人在不同情况下自我报告的洗手频率
BMC Public Health. 2024 Dec 24;24(1):3581. doi: 10.1186/s12889-024-21106-3.
7
Divergent Cortical Tau Positron Emission Tomography Patterns Among Patients With Preclinical Alzheimer Disease.皮质 Tau 正电子发射断层扫描模式在临床前阿尔茨海默病患者中的差异。
JAMA Neurol. 2022 Jun 1;79(6):592-603. doi: 10.1001/jamaneurol.2022.0676.
8
Timeline to symptomatic Alzheimer's disease in people with Down syndrome as assessed by amyloid-PET and tau-PET: a longitudinal cohort study.淀粉样蛋白 PET 和 tau-PET 评估唐氏综合征患者症状性阿尔茨海默病的时间轴：一项纵向队列研究。
Lancet Neurol. 2024 Dec;23(12):1214-1224. doi: 10.1016/S1474-4422(24)00426-5.
9
Salivary levels of amyloid beta reflect brain amyloid beta burden in cognitively-normal older adults.认知功能正常的老年人唾液中β-淀粉样蛋白水平反映脑内β-淀粉样蛋白负荷。
J Prev Alzheimers Dis. 2025 Jun 9:100216. doi: 10.1016/j.tjpad.2025.100216.
10
Contribution of Global Amyloid-PET Imaging for Predicting Future Cognition in the MEMENTO Cohort.全球淀粉样蛋白-PET 成像对 MEMENTO 队列未来认知的预测作用。
Neurology. 2024 Mar 26;102(6):e208054. doi: 10.1212/WNL.0000000000208054. Epub 2024 Feb 27.

引用本文的文献

1
The Status of Neuroimaging with SPECT and PET in Germany: Results from the 1st Survey on Nuclear Neuroimaging in Germany in 2023.德国单光子发射计算机断层扫描和正电子发射断层扫描神经成像的现状：2023年德国首次核神经成像调查结果
Nuklearmedizin. 2025 Apr 15. doi: 10.1055/a-2566-1487.

本文引用的文献

1
Lecanemab approval in EU: what should we be ready for?- the EANM perspective.欧盟批准lecanemab：我们应做好哪些准备？——欧洲核医学协会的观点
Eur J Nucl Med Mol Imaging. 2025 Apr;52(5):1607-1610. doi: 10.1007/s00259-025-07066-9.
2
Updated appropriate use criteria for amyloid and tau PET: A report from the Alzheimer's Association and Society for Nuclear Medicine and Molecular Imaging Workgroup.淀粉样蛋白和tau蛋白PET的更新后合理使用标准：阿尔茨海默病协会与核医学和分子影像学会工作组的报告
Alzheimers Dement. 2025 Jan;21(1):e14338. doi: 10.1002/alz.14338. Epub 2025 Jan 8.
3
Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup.
修订的阿尔茨海默病诊断和分期标准：阿尔茨海默病协会工作组。
Alzheimers Dement. 2024 Aug;20(8):5143-5169. doi: 10.1002/alz.13859. Epub 2024 Jun 27.
4
The path to next-generation disease-modifying immunomodulatory combination therapies in Alzheimer's disease.阿尔茨海默病下一代疾病修饰性免疫调节联合治疗策略。
Nat Aging. 2024 Jun;4(6):761-770. doi: 10.1038/s43587-024-00630-2. Epub 2024 Jun 5.
5
Patient-related benefits of amyloid PET imaging in dementia: Rationale and design of the German randomized coverage with evidence development study ENABLE.淀粉样蛋白PET成像在痴呆症中与患者相关的益处：德国随机覆盖与证据开发研究ENABLE的原理与设计。
Alzheimers Dement (N Y). 2023 Aug 8;9(3):e12383. doi: 10.1002/trc2.12383. eCollection 2023 Jul-Sep.
6
FDA approval of lecanemab: the real start of widespread amyloid PET use? - the EANM Neuroimaging Committee perspective.美国食品药品监督管理局批准仑卡奈单抗：淀粉样蛋白正电子发射断层扫描广泛应用的真正开端？——欧洲核医学与分子影像学会神经影像学委员会观点
Eur J Nucl Med Mol Imaging. 2023 May;50(6):1553-1555. doi: 10.1007/s00259-023-06177-5.
7
Myocardial perfusion SPECT in Germany from 2012 to 2021: insights into development and quality indicators.德国 2012 年至 2021 年心肌灌注 SPECT：发展洞察与质量指标。
Eur J Nucl Med Mol Imaging. 2023 May;50(6):1621-1628. doi: 10.1007/s00259-023-06129-z. Epub 2023 Feb 13.
8
The approval of a disease-modifying treatment for Alzheimer's disease: impact and consequences for the nuclear medicine community.一种用于治疗阿尔茨海默病的疾病修饰疗法的获批：对核医学领域的影响及后果
Eur J Nucl Med Mol Imaging. 2021 Sep;48(10):3033-3036. doi: 10.1007/s00259-021-05485-y.
9
Appropriate use criteria for dementia amyloid imaging in Switzerland - mini-review and statement on behalf of the Swiss Society of Nuclear Medicine and the Swiss Memory Clinics.瑞士痴呆症淀粉样蛋白成像的合理使用标准 - 迷你评论和代表瑞士核医学学会和瑞士记忆诊所的声明。
Nuklearmedizin. 2021 Feb;60(1):7-9. doi: 10.1055/a-1277-6014. Epub 2020 Oct 20.
10
APOE and Alzheimer disease: a major gene with semi-dominant inheritance.载脂蛋白 E 与阿尔茨海默病：一个具有半显性遗传的主要基因。
Mol Psychiatry. 2011 Sep;16(9):903-7. doi: 10.1038/mp.2011.52. Epub 2011 May 10.